| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |